Jessica Foley shared her perspective in a recent panel discussion.

Rivanna announces the market introduction of Accuro Second Generation, combining innovative thoracic spine functionality with its groundbreaking introductory system.

Bonumose, Inc., announces the closing of Series B investments co-led by The Hershey Company and American Sugar Refining, Inc.

Company establishes new facilities in Utah and New Hampshire to produce “Spitfire” platform for high-quality performance at the point-of-need.

HemoShear is enhancing its management team as the company readies to enter the clinic and expand its pipeline.

The company’s software uses machine learning and computer vision to create a predictive algorithm, reducing the error range for diagnosis.

Expansion of leadership expected to accelerate commercial growth opportunities and R&D.

Contraline has developed ADAM™, the world’s first injectable hydrogel designed to provide long-lasting barrier contraception for men.

Headquartered outside of Washington, DC, NDA Partners was founded in 2003 by 10 former FDA officials and pharmaceutical industry executives who have pioneered some of the most innovative modern approaches...

HemoShear will receive an upfront payment and funding to develop a new human tissue-based model of a rare liver disease using the company’s REVEAL-Tx™ Platform.

AgroSpheres today announced a strategic alliance with Orion Integrated Biosciences to create the next generation of environmentally friendly, cost-effective and reliable RNAi pesticide products.

TearSolutions, Inc. announced today the successful completion and preliminary outcomes of a Phase I/II trial of LacripepTM in Primary Sjögren’s Syndrome (PSS) patients.